- Home
- IFRX vs SLGB Comparison
IFRX vs SLGB Comparison
Compare IFRX & SLGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IFRX | SLGB |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | Germany | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated Freight & Logistics |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.0M | 75.4M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IFRX | SLGB |
|---|---|---|
| Price | $0.83 | $1.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 609.3K | ★ 9.0M |
| Earning Date | 03-19-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $73,729.00 | ★ $99,438,843.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,054.36 | N/A |
| P/E Ratio | ★ N/A | $37.54 |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $0.71 | $0.92 |
| 52 Week High | $2.77 | $6.08 |
Technical Indicators
Market Signals| Indicator | IFRX | SLGB |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 46.10 |
| Support Level | $0.88 | $1.02 |
| Resistance Level | $1.01 | $4.22 |
| Average True Range (ATR) | 0.09 | 0.87 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 8.87 | 10.20 |
Price Performance
Historical ComparisonAbout IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About SLGB Smart Logistics Global Limited Ordinary Shares
Smart Logistics Global Ltd is a contract logistics solution provider in the PRC focusing on industrial raw materials line-haul transportation business. the group focuses on the logistics digital ecosystem through innovation, digital analytics, and infrastructure establishment.